Contact
Header_1077x260px_About_Profil.jpg

Glucose-Infusion-Rate based categorization of glucose clamps

Update on Brexit: Impact on future and current clinical trials in Germany

Pramlintide as adjunct therapy for the treatment of type 1 diabetes

New data on cardiovascular outcomes with SGLT2 inhibitors

Glucose-Responsive Insulin

New timelines for the EU Portal and implementation of the EU Clinical Trial Regulation

Work stress is the new smoking

Even moderate overweight increases the risk for cardiovascular disease, recent study says

Clamp studies with ultra-long-acting insulins – New challenges for an old procedure

Gut Microbiota and Type 2 Diabetes